The “EV71 inactivated vaccine” of the company has received CFDA approval and may be the first commercial vaccine of this type in the world. By the end of 2015, HFMD disease caused by infection of enterovirus 71 had affected nearly 14 million victims in China, and infant mortality reached over 3300 cases. Protection rate by the vaccine reached nearly 100 %

China Bio news release, January 15, 2016